在健康成年人中,有哪些临床证据支持非标签拉巴胺治疗?
Jacob M Hands1, Michael S Lustgarten2, Leigh A Frame1
1The George Washington University School of Medicine and Health Sciences, Washington DC, DC 20037, USA.
Aging
|August 8, 2025
概括
低剂量拉巴胺对健康衰老有希望,但人类数据仍然有限. 需要进一步的研究来证实它作为老年人中老年治疗干预的有效性.
科学领域:
- 老年学和长寿研究研究.
- 药理学和药物开发领域
背景情况:
- 低剂量拉巴胺素 (sirolimus) 和其类型 (rapalogs) 正在研究它们延长寿命的潜力.
- 临床前研究表明,拉巴胺可以提高平均和最大寿命.
研究的目的:
- 对健康的老年人中低剂量拉巴素和拉帕洛格疗法的现有证据进行审查.
- 模拟队列研究结果,使用PhenoAge模型来评估衰老延迟.
主要方法:
- 对长寿的拉帕米辛/拉帕洛格斯人体研究的系统审查.
- 将PhenoAge模型应用于队列数据的应用.
主要成果:
- 目前的人类数据不足以确定拉帕米辛或拉帕洛格作为健康衰老的已被证明的老年疗法.
- 关于延长寿命的临床前发现尚未在人体试验中得到明确复制.
结论:
- 拉帕米辛和拉帕洛格需要在更大的人类队伍中进行进一步的研究.
- 需要更多的研究来确定这些药物在延迟人类衰老中的有效性.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21


